140 related articles for article (PubMed ID: 16813879)
1. Prostate specific antigen testing in men older than 75 years in the United States.
Scales CD; Curtis LH; Norris RD; Schulman KA; Albala DM; Moul JW
J Urol; 2006 Aug; 176(2):511-4. PubMed ID: 16813879
[TBL] [Abstract][Full Text] [Related]
2. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
McNaughton Collins M; Stafford RS; Barry MJ
J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
[TBL] [Abstract][Full Text] [Related]
3. PSA testing in office-based clinics: are we testing as much as we think?
González HM; West B; Underwood W
J Am Coll Surg; 2005 Dec; 201(6):906-12. PubMed ID: 16310694
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
5. Trends in prostate-specific antigen testing from 1995 through 2004.
Farwell WR; Linder JA; Jha AK
Arch Intern Med; 2007 Dec; 167(22):2497-502. PubMed ID: 18071173
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of prostate specific antigen testing for prostate cancer in elderly men.
Dyche DJ; Ness J; West M; Allareddy V; Konety BR
J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807
[TBL] [Abstract][Full Text] [Related]
7. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
Kuo NW; Lin HC; Lee HC
J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533
[TBL] [Abstract][Full Text] [Related]
8. Practice patterns in screening and management of prostate cancer in elderly men.
Konety BR; Sharp VJ; Verma M; Williams RD;
Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
Jønler M; Eddy B; Poulsen J
Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
[TBL] [Abstract][Full Text] [Related]
10. Total and percent free prostate-specific antigen levels among U.S. men, 2001-2002.
Saraiya M; Kottiri BJ; Leadbetter S; Blackman D; Thompson T; McKenna MT; Stallings FL
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2178-82. PubMed ID: 16172229
[TBL] [Abstract][Full Text] [Related]
11. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000.
Han PK; Coates RJ; Uhler RJ; Breen N
Am J Prev Med; 2006 May; 30(5):394-404. PubMed ID: 16627127
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen testing: uncovering primary care influences.
Gormley GJ; Catney D; McCall JR; Reilly PM; Gavin AT
BJU Int; 2006 Nov; 98(5):996-1000. PubMed ID: 17034601
[TBL] [Abstract][Full Text] [Related]
13. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
[TBL] [Abstract][Full Text] [Related]
14. Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.
Moul JW; Sun L; Hotaling JM; Fitzsimons NJ; Polascik TJ; Robertson CN; Dahm P; Anscher MS; Mouraviev V; Pappas PA; Albala DM
J Urol; 2007 Feb; 177(2):499-503; discussion 503-4. PubMed ID: 17222618
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey.
Ross LE; Coates RJ; Breen N; Uhler RJ; Potosky AL; Blackman D
Prev Med; 2004 Jun; 38(6):732-44. PubMed ID: 15193893
[TBL] [Abstract][Full Text] [Related]
16. Screening for prostate cancer: a comparison of urologists and primary care physicians.
McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
[TBL] [Abstract][Full Text] [Related]
17. Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras.
Sun L; Caire AA; Robertson CN; George DJ; Polascik TJ; Maloney KE; Walther PJ; Stackhouse DA; Lack BD; Albala DM; Moul JW
J Urol; 2009 Nov; 182(5):2242-8. PubMed ID: 19758616
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
19. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
20. Prostate brachytherapy: a descriptive analysis from CaPSURE.
Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]